Compare Southwest Airlines Co (LUV) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Southwest Airlines Co vs Stryker Corporation — how do they compare? Southwest Airlines Co trades at $41.66 (market cap $20.23B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 5.3× Southwest Airlines Co's market cap, and Southwest Airlines Co pays the higher dividend (1.74%). Which is the better fit depends on your goals — on Pluang, investors hold Southwest Airlines Co for 65 Days and Stryker Corporation for 21 Days on average.
| LUV | SYK | |
|---|---|---|
Market Cap | $20.23B | $106.24B |
Volume | 14,560,422 | 2,982,001 |
Sector | Industrials | Health |
52-Week High | $54.80 | $388.35 |
52-Week Low | $29.67 | $269.75 |
Typical Hold Time | 65 Days | 21 Days |
Enterprise Value | $23.33B | $117.70B |
Dividend Yield | 1.74% | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Southwest Airlines (LUV) trades at $41.66, down 0.14% with a bearish technical signal. The stock shows mixed earnings performance with a recent Q2 beat but Q1 miss. Valuation metrics appear reasonable with P/E of 25.85 and P/S of 0.72. The company is undergoing a commercial transformation with new fare structures expected to generate significant EBIT growth, though net margins remain thin at 2.78%. Cash flow trends show improvement projected for 2026 with positive net cash flow of $316M.
LUV presents a turnaround opportunity with its revenue transformation initiatives targeting over $2 billion EBIT in 2026. The 19% upside to consensus price target of $49.61 offers potential reward, but risks include high fuel costs, competitive pressure from legacy carriers, and execution challenges. Analyst sentiment is mixed with 42% buy ratings amid ongoing operational changes.
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
